Skip to main content

Table 1 Demographic characteristics of the patients with tuberculosis in Taiwan

From: Utilization of Chinese medicine for respiratory discomforts by patients with a medical history of tuberculosis in Taiwan

Variable Non-CM users CM users P-value
n = 1874 (44.753%) n = 2051 (52.25%)
n % n %
Sex      <.0001*
 Female 354 18.89 861 41.98  
 Male 1520 81.11 1190 58.02  
Age at baseline (year)      <.0001*
 18–29 100 5.34 293 14.29  
 30–39 127 6.78 242 11.8  
  ≥ 40 1647 87.89 1516 73.92  
 Mean (SD) 64.06 (17.68) 53.25 (18.03) <.0001‡
Urbanization      <.0001*
 1 (highest) 408 21.77 529 25.8  
 2 431 23 607 29.61  
 3 327 17.45 345 16.83  
 4 354 18.89 306 14.93  
 5+ (lowest) 354 18.89 263 12.83  
Drug used
 rifampin 1819 97.07 2005 97.76 0.1714*
 ethambutol 1796 95.84 1985 96.78 0.116*
 isoniazid 1802 96.16 1972 96.15 0.9874*
 pyrazinamide 1581 84.36 1798 87.66 0.0028*
 levofloxacin 456 24.33 536 26.13 0.1948*
 streptomycin 131 6.99 113 5.51 0.055*
 kanamycin 73 3.9 81 3.95 0.9308*
 prothionamide 18 0.96 24 1.17 0.5237*
 cyclosporine 2 0.11 5 0.24 0.456$
 moxifloxacin 0 0 1 0.05
Interval between the onset oftuberculosis and the first CM consultation, days(median)   1395 (1068)
  1. ‡ t-test; * chi-square; $ Fisher’s exact test
  2. Abbreviation: SD standard deviation, CM Chinese Medicine
  3. † CM users referred to patients with history of TB who had visited CM clinics and had CM outpatient clinical records of tuberculosis or respiratory diseases